New Key Statistics Module, Z-Score and F-Score
NAS:IOVA Key Ratios
| Market Cap $ M | 3,602.71 |
| Enterprise Value $ M | 3,271.85 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.58 |
| Price/Sales | 102.56 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 32.00 |
| EPS (TTM) $ | -1.67 |
| Beneish M-Score | 133.31 |
| 10-y EBITDA Growth Rate % | -9.90 |
| 5-y EBITDA Growth Rate % | -8.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -6.96 |
| EV-to-EBITDA | -7.63 |
| PEG | -- |
| Shares Outstanding M | 303.51 |
| Net Margin (%) | -1,343.27 |
| Operating Margin % | -1,401.36 |
| Pre-tax Margin (%) | -1,361.17 |
| Quick Ratio | 4.85 |
| Current Ratio | 5.15 |
| ROA % (ttm) | -52.11 |
| ROE % (ttm) | -66.99 |
| ROIC % (ttm) | -92.77 |
| Dividend Yield % | -- |
| Altman Z-Score | 6.57 |
IOVA Number of Guru Trades
IOVA Volume of Guru Trades
Gurus Latest Trades with NAS:IOVA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:IOVA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Iovance Biotherapeutics Inc Insider Transactions
No Available Data
News about NAS:IOVA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers